Nature Reviews Disease Primers· 2015Q1· Review
Attention-deficit/hyperactivity disorder
- 1,363citations
- Q1SCImago
- 2015year
Short summary
ADHD affects 5% of children and 2.5% of adults globally, increasing lifetime risk for psychiatric disorders, educational/occupational failure, accidents, criminality, social disability, and addictions.
AI-generated from the title and abstract; the full text is not read.
Key points
- ADHD is a persistent neurodevelopmental disorder affecting 5% of children and 2.5% of adults globally.
- It increases lifetime risk for psychiatric disorders, educational/occupational failure, accidents, criminality, social disability, and addictions.
- ADHD arises from multiple genetic and environmental risk factors, leading to heterogeneity in presentation.
- Diagnosis is reliable and valid using standard criteria, facilitated by rating scales and clinical interviews.
- Evidenced-based treatments, including medications and non-pharmacological methods, can significantly reduce symptoms and impairments.
AI-generated from the title and abstract; the full text is not read.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a persistent neurodevelopmental disorder that affects 5% of children and adolescents and 2.5% of adults worldwide. Throughout an individual's lifetime, ADHD can increase the risk of other psychiatric disorders, educational and occupational failure, accidents, criminality, social disability and addictions. No single risk factor is necessary or sufficient to cause ADHD. In most cases ADHD arises from several genetic and environmental risk factors that each have a small individual effect and act together to increase susceptibility. The multifactorial causation of ADHD is consistent with the heterogeneity of the disorder, which is shown by its extensive psychiatric co-morbidity, its multiple domains of neurocognitive impairment and the wide range of structural and functional brain anomalies associated with it. The diagnosis of ADHD is reliable and valid when evaluated with standard criteria for psychiatric disorders. Rating scales and clinical interviews facilitate diagnosis and aid screening. The expression of symptoms varies as a function of patient developmental stage and social and academic contexts. Although there are no curative treatments for ADHD, evidenced-based treatments can markedly reduce its symptoms and associated impairments. For example, medications are efficacious and normally well tolerated, and various non-pharmacological approaches are also valuable. Ongoing clinical and neurobiological research holds the promise of advancing diagnostic and therapeutic approaches to ADHD. For an illustrated summary of this Primer, visit: http://go.nature.com/J6jiwl Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects children and adults. In this Primer, Faraone and colleagues argue that improved understanding of the heterogeneous genetic and environmental mechanisms underlying ADHD is required to improve diagnosis and treatment.
The authors' abstract, as published at the source. Nature Reviews Disease Primers, 2015 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Psychiatry and Mental health
Psychiatry and Mental healthMedicine